Jane Street Group, LLC Enlivex Therapeutics Ltd. Transaction History

Jane Street Group, LLC

  • $616 Billion
  • Q3 2025

A detailed history of Jane Street Group, LLC transactions in Enlivex Therapeutics Ltd. stock. As of the latest transaction made, Jane Street Group, LLC holds 21,529 shares of ENLV stock, worth $21,098. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,529
Previous 61,052 64.74%
Holding current value
$21,098
Previous $68,000 69.12%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$1.01 - $1.82 $39,918 - $71,931
-39,523 Reduced 64.74%
21,529 $21,000
Q2 2025

Aug 14, 2025
SELL
$0.86 - $1.26 $16,948 - $24,830
-19,707 Reduced 24.4%
61,052 $68,000
Q1 2025

May 14, 2025
BUY
$0.97 - $1.24 $65,849 - $84,178
67,886 Added 527.35%
80,759 $78,000
Q4 2024

Feb 14, 2025
BUY
$0.84 - $1.69 $10,813 - $21,755
12,873 New
12,873 $14,000
Q2 2022

Aug 16, 2022
SELL
$3.81 - $8.64 $200,051 - $453,660
-52,507 Closed
0 $0
Q1 2022

May 17, 2022
BUY
$4.92 - $6.66 $122,050 - $165,214
24,807 Added 89.56%
52,507 $294,000
Q4 2021

Feb 15, 2022
BUY
$5.81 - $9.73 $96,672 - $161,897
16,639 Added 150.43%
27,700 $173,000
Q3 2021

Nov 16, 2021
BUY
$7.43 - $13.86 $3,989 - $7,442
537 Added 5.1%
11,061 $109,000
Q2 2021

Aug 16, 2021
SELL
$8.61 - $12.1 $4,701 - $6,606
-546 Reduced 4.93%
10,524 $94,000
Q1 2021

May 18, 2021
BUY
$9.26 - $24.0 $102,508 - $265,680
11,070 New
11,070 $123,000
Q4 2020

Feb 17, 2021
SELL
$8.16 - $14.5 $88,185 - $156,701
-10,807 Closed
0 $0
Q3 2020

Nov 17, 2020
SELL
$4.64 - $5.94 $92,354 - $118,229
-19,904 Reduced 64.81%
10,807 $64,000
Q2 2020

Aug 17, 2020
BUY
$4.4 - $6.4 $135,128 - $196,550
30,711 New
30,711 $155,000
Q4 2019

Feb 14, 2020
SELL
$6.61 - $27.48 $156,359 - $650,039
-23,655 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$19.7 - $39.42 $466,003 - $932,480
23,655 New
23,655 $632,000

Others Institutions Holding ENLV

# of Institutions
32
Shares Held
930K
Call Options Held
0
Put Options Held
0
View Full List

About Enlivex Therapeutics Ltd.

ENLV Quotes by TradingView
  • Ticker ENLV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,403,200
  • Market Cap $18M
  • Description
  • Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2...
More about ENLV
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email